What is zinc transporter 8?
What is zinc transporter 8?
Zinc transporter 8 (ZnT8), a protein highly specific to pancreatic insulin-producing beta cells, is vital for the biosynthesis and secretion of insulin. ZnT8 autoantibodies (ZnT8A) are among the most recently discovered and least-characterised islet autoantibodies.
What has zinc transporter 8 autoimmunity taught us about type 1 diabetes?
ZnT8 autoantibodies (ZnT8A) are among the most recently discovered and least-characterised islet autoantibodies. In combination with autoantibodies to several other islet antigens, including insulin, ZnT8A help predict risk of future type 1 diabetes.
What is zinc transporter test?
OBJECTIVE Zinc transporter 8 (ZnT8) is an islet β-cell secretory granule membrane protein recently identified as an autoantibody antigen in type 1 diabetes. The aim of this study was to determine the prevalence and role of antibodies to ZnT8 (ZnT8As) in adult-onset diabetes.
What is a IA 2 antibody?
IA-2 Antibody – Type 1 Diabetes Mellitus is characterized by lymphocytic cell infiltration of the beta-cells of pancreatic islets. Measurement of IA-2, GAD-65, ICA-512, and Insulin Antibody is a highly sensitive means to assess risk and predict onset of Type I diabetes.
What are GAD antibodies?
GAD antibodies belong to a group of diabetes-associated antibodies that instruct the immune system to destroy the insulin-producing pancreatic cells. When insulin production stops, diabetes develops. As these antibodies target and react with the body’s cells, the medical community refers to them as autoantibodies.
What does positive GAD antibodies mean?
The presence of GAD autoantibodies indicates an immune system attack, which points to type 1 diabetes. Type 1 diabetes isn’t the only reason someone might have GAD autoantibodies. These antibodies are also linked to other conditions, which include: Cerebellar ataxia.
Do all type 1 diabetics have antibodies?
Autoantibodies against GAD 65 are found in 80% of patients with type 1 diabetes at clinical presentation[3]. Presence of ICA and IA-2A at diagnosis for type 1 diabetes range from 69-90% and 54-75%, respectively[11].
Is GAD an autoimmune disease?
The main autoimmune targets are glutamic acid decarboxylase (GAD), amphiphysin, GABA receptors and glycine receptors. GAD antibodies predominantly occur in stiff-person syndrome, cerebellar ataxia and epilepsy, and sometimes in encephalitis.
What does positive GAD mean?
Which is an autoantigen of zinc transporter 8?
(1) Since 1988, several autoantigens against which islet antibodies are directed have been identified. These include the insulinoma-associated protein 2 (IA-2), glutamic acid decarboxylase 65 (GAD65), insulin, and, most recently, the zinc transporter ZnT8.
When did the first zinc transporter 8 test come out?
As of 2014, the United States Food and Drug Administration allowed marketing of the first zinc transporter 8 autoantibody ( ZnT8Ab) test. This can help determine if an individual has type 1 diabetes or another type of the disease.
What do you need to know about ZnT8 antibody?
Zinc Transporter 8 (ZnT8) Antibody, Serum Useful For Suggests clinical disorders or settings where the test may be helpful Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
Which is the epitope of the ZnT8 protein?
However, a majority of ZNT8 autoantibodies (~ 80%) react with the epitopes in the C-terminal end of the ZNT8 protein ( Achenbach et al., 2009; Wenzlau et al., 2007 ). Moreover, the epitope containing R325 is a major determinant for the ZNT8 autoimmunity ( Wenzlau et al., 2007 ).
